Thomas

Thomas: Email & Phone Number

Opt-Out
VP, Drug Creation Biology at Absci|United States

Position:

VP, Drug Creation Biology at Absci

Location:

United States

LinkedIn
View Thomas's Email
Up to 10 free lookups. No credit card required.
Last updated: 2025-12-19
Updated: 2025-12-19

Found email addresses for Thomas:

Business emails:

Found phone for Thomas:

Searching for Thomas profiles
0% completed

A different Thomas?

Sign up to search for other Thomas's across our 850M+ professionals database

Work Experience 14 years

VP, Drug Creation Biology at Absci

Jan 2024 - Current

Director, Head of Emerging Science Biology, Target Sciences, Emerging Science & Innovation (ES&I) at Pfizer

Jan 2019 - Jan 2024

Research Project Leader (Sr Principal Scientist) Centers for Therapeutic Innovation (CTI) at Pfizer

Jan 2019 - Jan 2020

Research Project Leader (Principal scientist), Centers for Therapeutic Innovation (CTI) at Pfizer

Jan 2016 - Jan 2019

Investigator at GSK

Jan 2012 - Jan 2016

Thomas started working in 2012, then the employee has changed 2 companies and 4 jobs. On average, Thomas works for one company for 3 years 1 month.

Their professional focus is Animal Models, Assay Development, and Assay Development across 3 core areas.

Education

Doctor of Philosophy - PhD at University of Michigan - Rackham Graduate School

Master's degree at University of Michigan - Rackham Graduate School

Frequently Asked Questions

What is Thomas's email address?

SignalHire found a verified business email address for Thomas: **@absci.com.

What is Thomas's phone number?

SignalHire found a verified phone number for Thomas: +1-***-***-6547.

How do I contact Thomas at Absci?

You can reach Thomas through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.

What is Thomas's professional background?

Thomas has 14 years of professional experience. They have held roles including Director, Head of Emerging Science Biology, Target Sciences, Emerging Science & Innovation (ES&I), Research Project Leader (Sr Principal Scientist) Centers for Therapeutic Innovation (CTI), and Research Project Leader (Principal scientist), Centers for Therapeutic Innovation (CTI) at companies such as Pfizer, Pfizer, and Pfizer. Their education includes Doctor of Philosophy - PhD from University of Michigan - Rackham Graduate School, and Master's degree from University of Michigan - Rackham Graduate School.

Is Thomas's contact information up to date?

Yes. Thomas's SignalHire profile was last updated on 19 December 2025, reflecting their current position as VP, Drug Creation Biology at Absci in Vancouver, Washington, United States.

Thomas Namesakes

Name
Company
Position
Thomas
Drafter II / 3d Designer / Inventor Ilogic Designer
Get contacts
Thomas
Back of House Training Manager
Get contacts
Thomas
Maintenance Technician
Get contacts
See more profiles

Other employees at Absci

Name
Company
Position
Nyah Boyd
Laboratory Technician III
Get contacts
Marta Viseu Sarrico
Senior Machine Learning Engineer
Get contacts
Daisy Chen
Engineering Manager / Technology Leader
Get contacts
Tristan BERTIN
AI Scientist - AI Protein Design
Get contacts
Benarex Koffi
Technicien électromécanique
Get contacts
Audree Feltner
Senior Laboratory Technician
Get contacts
Ashley Gladfelder
Laboratory Technician
Get contacts
Douglas Ganini da Silva
Director of Purification, Analytics and CMC
Get contacts
Praveen
AI Machine Learning Engineer
Get contacts
Dylan Porter
Laboratory Technician
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP